Industry Seeks CMS Guidance On Preclinical Meetings, Trial Design
Executive Summary
Industry is seeking guidance from the Centers for Medicare & Medicaid Services on designing clinical trials to satisfy standards for Medicare national coverage decisions
You may also be interested in...
CMS Developing Guidance On Coverage Decisions For Clinical Trials
The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries
CMS Developing Guidance On Coverage Decisions For Clinical Trials
The Centers for Medicare & Medicaid Services will produce a guidance document on Medicare coverage of products used in clinical trials or registries
CMS Off-Label Coverage Decision For Colorectal Cancer Rx Coming Soon
The Centers for Medicare & Medicaid Services expects to release proposed national coverage determinations on off-label use of colorectal cancer drugs in the "near future," CMS Chief Medical Officer Sean Tunis, MD, said Sept. 30 at a CMS workshop in Baltimore